Increased Osteoblast Activity and Bone Formation Confirmed in Cell and Animal Experiments; Osteoclast Activity Decreased
Key Components of Saposhnikovia divaricata Also Shown to Bind Proteins Related to Bone Formation and Resorption

The research team led by Dr. Hyunsung Kim at the Jaseng Spine and Joint Research Institute of Jaseng Oriental Medicine Hospital announced on September 28, 2026, that an extract of Saposhnikovia divaricata, a traditional herbal medicine, has been found to promote bone regeneration in both cell and animal experiments. The research findings were recently published in the international journal "Advanced Biology."


Bangkong (Saposhnikoviae Radix), dried and thinly sliced for use as herbal medicine. Jaseng Oriental Medicine Hospital

Bangkong (Saposhnikoviae Radix), dried and thinly sliced for use as herbal medicine. Jaseng Oriental Medicine Hospital

View original image

According to the study, when varying concentrations of Saposhnikovia divaricata extract were applied to osteoblast cells derived from laboratory mice, osteoblast differentiation was promoted without any cellular toxicity. Both alkaline phosphatase (ALP) activity, a marker of bone formation, and calcium deposition increased. In addition, the expression of genes involved in osteoblast differentiation (RUNX2) and bone matrix formation (Col1a1) was elevated.


In animal experiments, researchers induced defects in the femurs of laboratory mice and administered the Saposhnikovia divaricata extract for one week. Micro-computed tomography (micro-CT) analysis revealed that higher doses of the extract led to increased amounts of newly formed bone and enhanced bone mineral density. The number of TRAP-positive cells, indicating osteoclast activity, decreased, while the expression of osteocalcin, a marker of bone formation, increased.


The study also confirmed the potential of major active components of Saposhnikovia divaricata to bind to proteins involved in bone formation and resorption. Molecular docking simulations suggested that prim-O-glucosylcimifugin and other key components could stably bind to RANK, which is associated with osteoclast generation and activity, as well as RUNX2, involved in osteoblast formation.


The research team explained that Saposhnikovia divaricata may promote bone regeneration by simultaneously enhancing the bone-forming activity of osteoblasts and inhibiting the activity of osteoclasts.



Dr. Hyunsung Kim of the Jaseng Spine and Joint Research Institute stated, "We have confirmed the potential of Saposhnikovia divaricata to contribute to fracture healing by regulating both bone formation and bone resorption. Moving forward, we plan to conduct long-term observational studies to further substantiate the evidence for using Saposhnikovia divaricata and herbal prescriptions containing it in fracture treatment."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing